It’s been nearly 15 years since San Diego’s Illumina gained supremacy in DNA sequencing — with just a few rivals competing to deliver the equipment and chemistry to map the genome. But that’s started ...

Illumina DNA sequencing machines are vulnerable to exploitation. Both the Cybersecurity and Infrastructure Security Agency (CISA) and the Food and Drug Administration (FDA) have published advisories ...

San Diego’s Illumina is getting closer to sequencing full human genomes at a cost that’s considered the sweet spot for driving wider adoption of personalized medicine based on a patient’s DNA. At its ...

Illumina is welcoming a new addition to its DNA sequencing lineup, with a pair of accessible benchtop instruments that incorporate the tech and chemistry used by its largest, top-of-the-line machines.

May 6 (Reuters) - A Delaware jury on Friday ordered Illumina Inc ILMN.O to pay more than $333 million to a U.S. unit of Chinese genetic analysis company BGI Genomics ...

Illumina has refreshed its commitment to chase higher profit margins, with a plan to cut at least $100 million from its annual expenses and slim down operations, all set to take effect later this year ...

Illumina CEO Francis deSouza unveils the NovaSeq X Series sequencing platforms. San Diego-based genomics pioneer Illumina on Thursday introduced a new machine that will sequence a human genome in half ...

Healthcare providers and lab workers using Illumina genetic sequencing instruments are advised to immediately patch the device software against a new vulnerability that the Food and Drug ...

May 6 (Reuters) - A Delaware jury on Friday ordered Illumina Inc ILMN.O to pay more than $333 million to a U.S. unit of Chinese genetic analysis company BGI Genomics ...

The human genome is made of more than 6 billion letters, and each person has a unique configuration of As, Cs, Gs, and Ts—the molecular building blocks that make up DNA. Determining the sequence of ...